cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide

C163H316N24O23 — CID 162009942

IUPACcis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide
SMILESCN(C)CCN(C)C(=O)CCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CCCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CN(C)CC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)COCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)c1cnccc1C(=O)C(C)(C)C.CN(CCN1CCCCC1)C(=O)[C@H]1CCCC[C@H]1C(=O)C(C)(C)C.C[C@@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CCC(=O)C(C)(C)C)C(=O)N(C)CCN(C)C.C[C@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C
InChIInChI=1S/C20H36N2O2.C16H25N3O2.3C15H30N2O2.C14H29N3O2.3C14H28N2O2.C13H26N2O3.C13H26N2O2/c1-20(2,3)18(23)16-10-6-7-11-17(16)19(24)21(4)14-15-22-12-8-5-9-13-22;1-16(2,3)14(20)12-7-8-17-11-13(12)15(21)19(6)10-9-18(4)5;2*1-12(14(19)15(2,3)4)8-9-13(18)17(7)11-10-16(5)6;1-12(8-9-13(18)15(2,3)4)14(19)17(7)11-10-16(5)6;1-14(2,3)12(18)10-16(6)11-13(19)17(7)9-8-15(4)5;2*1-11(13(18)14(2,3)4)10-12(17)16(7)9-8-15(5)6;1-14(2,3)12(17)8-7-9-13(18)16(6)11-10-15(4)5;1-13(2,3)11(16)9-18-10-12(17)15(6)8-7-14(4)5;1-13(2,3)11(16)7-8-12(17)15(6)10-9-14(4)5/h16-17H,5-15H2,1-4H3;7-8,11H,9-10H2,1-6H3;3*12H,8-11H2,1-7H3;8-11H2,1-7H3;2*11H,8-10H2,1-7H3;7-11H2,1-6H3;7-10H2,1-6H3;7-10H2,1-6H3/t16-,17+;;3*12-;;2*11-;;;/m1.101.10.../s1
InChIKeyYTILCKHWFVEFSH-IVKHOJENSA-N
MW2980.47 g/mol
LogP19.09
Rot. Bonds70

About cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide

cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide (PubChem CID 162009942) has the molecular formula C163H316N24O23 and a molecular weight of 2980.47 g/mol. Its IUPAC name is cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide.

Molecular Properties

Compound Namecis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide
PubChem CID162009942
Molecular FormulaC163H316N24O23
Molecular Weight2980.47 g/mol
Exact Mass2978.43
IUPAC Namecis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide
SMILESCN(C)CCN(C)C(=O)CCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CCCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CN(C)CC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)COCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)c1cnccc1C(=O)C(C)(C)C.CN(CCN1CCCCC1)C(=O)[C@H]1CCCC[C@H]1C(=O)C(C)(C)C.C[C@@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CCC(=O)C(C)(C)C)C(=O)N(C)CCN(C)C.C[C@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C
InChIInChI=1S/C20H36N2O2.C16H25N3O2.3C15H30N2O2.C14H29N3O2.3C14H28N2O2.C13H26N2O3.C13H26N2O2/c1-20(2,3)18(23)16-10-6-7-11-17(16)19(24)21(4)14-15-22-12-8-5-9-13-22;1-16(2,3)14(20)12-7-8-17-11-13(12)15(21)19(6)10-9-18(4)5;2*1-12(14(19)15(2,3)4)8-9-13(18)17(7)11-10-16(5)6;1-12(8-9-13(18)15(2,3)4)14(19)17(7)11-10-16(5)6;1-14(2,3)12(18)10-16(6)11-13(19)17(7)9-8-15(4)5;2*1-11(13(18)14(2,3)4)10-12(17)16(7)9-8-15(5)6;1-14(2,3)12(17)8-7-9-13(18)16(6)11-10-15(4)5;1-13(2,3)11(16)9-18-10-12(17)15(6)8-7-14(4)5;1-13(2,3)11(16)7-8-12(17)15(6)10-9-14(4)5/h16-17H,5-15H2,1-4H3;7-8,11H,9-10H2,1-6H3;3*12H,8-11H2,1-7H3;8-11H2,1-7H3;2*11H,8-10H2,1-7H3;7-11H2,1-6H3;7-10H2,1-6H3;7-10H2,1-6H3/t16-,17+;;3*12-;;2*11-;;;/m1.101.10.../s1
InChIKeyYTILCKHWFVEFSH-IVKHOJENSA-N
XLogP19.09
TPSA472.18 Ų
H-Bond Donors
H-Bond Acceptors36
Rotatable Bonds70
Heavy Atoms210
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002980.47
LogP ≤ 519.09
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1036

Analyze cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide?
The IUPAC name of cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide (CID 162009942) is cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide.
What is the SMILES notation for cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide?
The canonical SMILES for cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide is CN(C)CCN(C)C(=O)CCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CCCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)CN(C)CC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)COCC(=O)C(C)(C)C.CN(C)CCN(C)C(=O)c1cnccc1C(=O)C(C)(C)C.CN(CCN1CCCCC1)C(=O)[C@H]1CCCC[C@H]1C(=O)C(C)(C)C.C[C@@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.C[C@H](CCC(=O)C(C)(C)C)C(=O)N(C)CCN(C)C.C[C@H](CCC(=O)N(C)CCN(C)C)C(=O)C(C)(C)C.
What is the InChIKey of cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide?
The InChIKey is YTILCKHWFVEFSH-IVKHOJENSA-N. The full InChI is InChI=1S/C20H36N2O2.C16H25N3O2.3C15H30N2O2.C14H29N3O2.3C14H28N2O2.C13H26N2O3.C13H26N2O2/c1-20(2,3)18(23)16-10-6-7-11-17(16)19(24)21(4)14-15-22-12-8-5-9-13-22;1-16(2,3)14(20)12-7-8-17-11-13(12)15(21)19(6)10-9-18(4)5;2*1-12(14(19)15(2,3)4)8-9-13(18)17(7)11-10-16(5)6;1-12(8-9-13(18)15(2,3)4)14(19)17(7)11-10-16(5)6;1-14(2,3)12(18)10-16(6)11-13(19)17(7)9-8-15(4)5;2*1-11(13(18)14(2,3)4)10-12(17)16(7)9-8-15(5)6;1-14(2,3)12(17)8-7-9-13(18)16(6)11-10-15(4)5;1-13(2,3)11(16)9-18-10-12(17)15(6)8-7-14(4)5;1-13(2,3)11(16)7-8-12(17)15(6)10-9-14(4)5/h16-17H,5-15H2,1-4H3;7-8,11H,9-10H2,1-6H3;3*12H,8-11H2,1-7H3;8-11H2,1-7H3;2*11H,8-10H2,1-7H3;7-11H2,1-6H3;7-10H2,1-6H3;7-10H2,1-6H3/t16-,17+;;3*12-;;2*11-;;;/m1.101.10.../s1.
What are the key properties of cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide?
cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide has a molecular weight of 2980.47 g/mol, XLogP of 19.09, 70 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for cis-(1S,2R)-2-(2,2-dimethylpropanoyl)-N-methyl-N-(2-piperidin-1-ylethyl)cyclohexane-1-carboxamide;N-[2-(dimethylamino)ethyl]-2-(3,3-dimethyl-2-oxobutoxy)-N-methylacetamide;N-[2-(dimethylamino)ethyl]-2-[(3,3-dimethyl-2-oxobutyl)-methylamino]-N-methylacetamide;N-[2-(dimethylamino)ethyl]-4-(2,2-dimethylpropanoyl)-N-methylpyridine-3-carboxamide;(2R)-N-[2-(dimethylamino)ethyl]-N,2,6,6-tetramethyl-5-oxoheptanamide;(4R)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(4S)-N-[2-(dimethylamino)ethyl]-N,4,6,6-tetramethyl-5-oxoheptanamide;(3R)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;(3S)-N-[2-(dimethylamino)ethyl]-N,3,5,5-tetramethyl-4-oxohexanamide;N-[2-(dimethylamino)ethyl]-N,6,6-trimethyl-5-oxoheptanamide;N-[2-(dimethylamino)ethyl]-N,5,5-trimethyl-4-oxohexanamide is sourced from PubChem (CID 162009942), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).